Citation 89149

YANG,YL: CHANG,FR: WU,CC: WANG,WY: WU,YC:. (2002). NEW ENT-KAURANE DITERPENOIDS WITH ANTI-PLATELET AGGREGATION ACTIVITY FROM ANNONA SQUAMOSA.. 65(10)

Citation Details

Title	NEW ENT-KAURANE DITERPENOIDS WITH ANTI-PLATELET AGGREGATION ACTIVITY FROM ANNONA SQUAMOSA.
Authors	YANG,YL: CHANG,FR: WU,CC: WANG,WY: WU,YC:
Year	2002
Volume	65
Issue	10

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Annona squamosa (ANNONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ANNOMOSIN A	None
3	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ANNOSQUAMOSIN C	None
4	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ANNOSQUAMOSIN D	None
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOSQUAMOSIN D	ACTIVE
6	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOSQUAMOSIN D	ACTIVE
7	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOSQUAMOSIN D	ACTIVE
8	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOSQUAMOSIN D	ACTIVE
9	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ANNOSQUAMOSIN E	None
10	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ANNOSQUAMOSIN F	None
11	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ANNOSQUAMOSIN G	None
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-17-OIC ACID,19-NOR: 4-ALPHA-HYDROXY: ENT:	None
13	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,19-NOR: 4-ALPHA-HYDROXY: ENT:	ACTIVE
14	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,19-NOR: 4-ALPHA-HYDROXY: ENT:	ACTIVE
15	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,19-NOR: 4-ALPHA-HYDROXY: ENT:	ACTIVE
16	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,19-NOR: 4-ALPHA-HYDROXY: ENT:	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ANNOSQUAMOSIN B	None
18	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOSQUAMOSIN B	ACTIVE
19	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOSQUAMOSIN B	ACTIVE
20	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOSQUAMOSIN B	ACTIVE
21	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOSQUAMOSIN B	ACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAUR-16-EN-19-OIC ACID,ENT:	None
23	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
24	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
25	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
26	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
27	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURANE-17-19-DIOIC ACID,16-ALPHA-HYDRO: ENT:	None
28	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURANE-17-19-DIOIC ACID,16-BETA-HYDRO: ENT:	None
29	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURANE-17-19-DIOIC ACID,16-BETA-HYDRO: ENT:	ACTIVE
30	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURANE-17-19-DIOIC ACID,16-BETA-HYDRO: ENT:	ACTIVE
31	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURANE-17-19-DIOIC ACID,16-BETA-HYDRO: ENT:	ACTIVE
32	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURANE-17-19-DIOIC ACID,16-BETA-HYDRO: ENT:	ACTIVE
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-OIC ACID,17-HYDROXY-16-ALPHA: ENT:	None
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-OIC ACID,17-HYDROXY-16-BETA: ENT:	None
35	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,17-HYDROXY-16-BETA: ENT:	ACTIVE
36	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,17-HYDROXY-16-BETA: ENT:	ACTIVE
37	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,17-HYDROXY-16-BETA: ENT:	ACTIVE
38	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,17-HYDROXY-16-BETA: ENT:	ACTIVE
39	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-OIC ACID,16-ALPHA-17-DIHYDROXY: ENT:	None
40	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA-17-DIHYDROXY: ENT:	ACTIVE
41	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA-17-DIHYDROXY: ENT:	ACTIVE
42	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA-17-DIHYDROXY: ENT:	ACTIVE
43	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA-17-DIHYDROXY: ENT:	INACTIVE
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-OIC ACID,16-BETA-17-DIHYDROXY: ENT:	None
45	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-BETA-17-DIHYDROXY: ENT:	ACTIVE
46	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-BETA-17-DIHYDROXY: ENT:	ACTIVE
47	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-BETA-17-DIHYDROXY: ENT:	ACTIVE
48	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-BETA-17-DIHYDROXY: ENT:	ACTIVE
49	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-OIC,17-ACETOXY-16-BETA-HYDROXY: ENT:	None
50	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC,17-ACETOXY-16-BETA-HYDROXY: ENT:	ACTIVE
51	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC,17-ACETOXY-16-BETA-HYDROXY: ENT:	ACTIVE
52	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC,17-ACETOXY-16-BETA-HYDROXY: ENT:	ACTIVE
53	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC,17-ACETOXY-16-BETA-HYDROXY: ENT:	ACTIVE
54	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL: ENT:	None
55	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL: ENT:	ACTIVE
56	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL: ENT:	ACTIVE
57	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL: ENT:	ACTIVE
58	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL: ENT:	ACTIVE
59	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-AL,17-HYDROXY-16-BETA: ENT:	None
60	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-AL,16-ALPHA-17-DIHYDROXY: ENT:	None
61	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-ALPHA-17-DIHYDROXY: ENT:	INACTIVE
62	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-ALPHA-17-DIHYDROXY: ENT:	ACTIVE
63	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-ALPHA-17-DIHYDROXY: ENT:	ACTIVE
64	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-ALPHA-17-DIHYDROXY: ENT:	ACTIVE
65	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-AL,16-BETA-17-DIHYDROXY: ENT:	None
66	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-BETA-17-DIHYDROXY: ENT:	ACTIVE
67	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-BETA-17-DIHYDROXY: ENT:	ACTIVE
68	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-BETA-17-DIHYDROXY: ENT:	ACTIVE
69	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-BETA-17-DIHYDROXY: ENT:	ACTIVE

Citation 89149

Citation Details

Summary

Organisms and Their Experiments (1)

Annona squamosa (ANNONACEAE)

Show SPARQL Queries (1)

Query 1